Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
Recent PostsMonday, October 13, 2014
The University of Florida’s Multi-functional Integrated System Technology (MIST) Center will play a leading role in researching the next generation of “smart” electronics funded by a National Science Foundation program that combines federal money with industry investments in strategic research. ..Read More ⇒Sunday, October 12, 2014
VGTI Florida, a leading, non-profit biomedical research institute, announced the launch of its Center for Diseases of Aging (“CDA”), a major initiative to accelerate the discovery and advancement of novel, best-in-class healthcare interventions for the prevention and treatment of diseases commonly associated with aging. ..Read More ⇒Friday, October 10, 2014
Researchers at the University of Central Florida set a new record in funded research in FY14, receiving $145.6 million, 30 percent more than the previous year. The funding totals reflect successful collaborations with industry, a record total for federal defense grants and continued growth in commercialization and innovation activity. ..Read More ⇒Thursday, October 09, 2014
A team of scientists led by Sanford-Burnham’s Ranjan J Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals. The study sets the stage for the development of more-sensitive and specific non-invasive tests for prostate cancer than those currently available, which could result in fewer unnecessary prostate biopsies with less treatment-related morbidity, according to a new study in The Journal of Molecular Diagnostics. ..Read More ⇒Wednesday, October 08, 2014
The University of Florida announced today the formation of the UF Diabetes Institute, a collaboration of dozens of researchers campuswide all focused on forging advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians. ..Read More ⇒
TagsFlorida International Univ. ecology magnets accreditation robotics University of West Florida nanotechnology HIV/AIDS computer science grants technology commercialization business education awards Banyan Biomarkers FAMU AGTC Univeristy of South Florida Florida Trend Florida Institute of Technology marine University of Miami conference / event photonics VGTI children environment health clean energy engineering GrowFL Scripps Research Institute Nova Southeastern Univ. partnerships Florida State University materials science green technology sciences sustainability accolades AxoGen ICFO health care Florida Atlantic University FL Institute for Commercialization of Public Research cancer biotechnology aging Torrey Pines Institute University of Florida aerospace Florida Gulf Coast Univ. BioFlorida physics economy astronomy gender animals consumers energy Florida Power & Light Embry-Riddle biomedical research policy Sanford-Burnham Moffitt Cancer Center bioscience Draper medical society/culture research Jackson Lab innovation Max Planck University of Central Florida stem cell IHMC Enterprise Florida agriculture policy University of North Florida Nanotheraputics Florida Hospital life science accounting neuroscience